hP, the component of log P controlling structure-activity relationships amongst non-steroidal anti-inflammatory drugs

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 3, 1996, Pages 233-239

  Dean, Francis M ^a,b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Pensby Hall ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC CARBOXYLIC ACID; CARBON; HYDROGEN; MEFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOL DERIVATIVE; PROSTAGLANDIN; SALICYLIC ACID DERIVATIVE; UNINDEXED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; HYDROPHOBICITY; MOUSE; NONHUMAN; PARTITION COEFFICIENT; PERITONEUM MACROPHAGE; PKA; STRUCTURE ACTIVITY RELATION;

EID: 0030012537     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb05908.x     Document Type: Article

References (29)

1. Akarasereenont, P., Mitchell, J. A., Thiemermann, C., Vane, J. A. (1994) Relative potency of nonsteroidal anti-inflammatory drugs as inhibitors of cyclooxygenase-1 or cyclooxygenase-2. Br. J. Pharmacol. (Suppl.) 112: 183P
2. Bradshaw, J., Taylor, P. J. (1989) Rationalisations among heterocyclic partition coefficients. Part 3. Excessive heterocycles. Some comments on the CLOG algorithm. Quant. Struct.-Act. Relat. 8: 279-287
3. Brune, K., Rainsford, K. D., Wagner, K., Peskar, B. A. (1981) Inhibition by anti-inflammatory drugs of prostaglandin production in cultured macrophages. Naunyn Schmiedebergs Arch. Pharmacol. 315. 269-276
4. Cullen, E. (1984) Novel anti-inflammatory agents. J. Pharm. Sci. 73: 579-589
5. Dearden, J. C., Nicholson, R. M. (1984) Correlation between gastric irritancy and anti-inflammatory activity of non-steroidal anti-inflammatory drugs. J. Pharm. Pharmacol. 36: 713-715
6. Dearden, J. C., Gregg, C. N., Nicholson, R. M. (1989) QSAR study of analgesic and anti-inflammatory potencies of commercially available nonsteroidal anti-inflammatory drugs. Prog. Clin. Biol. Res. 291: 353-356
7. Dewhirst, F. E. (1980) Structure-activity relationships for inhibition of prostaglandin cyclooxygenase by phenolic compounds. Prostaglandins 20: 209-222
8. Franke, R. (1984) Theoretical Drug Design Methods. Elsevier, Amsterdam
9. Gregg, C. N. (1991) Structure-activity studies on some non-steroidal anti-inflammatory drugs (Counc. Natl. Academic Awards. London, UK, 1989). Diss. Abstracts Int. 51: 4290-4579
10. Grennan, D. M., Higham, C. (1986) Non-steroidal anti-inflammatory drugs. In: Moll, J. M. H., Bird, H. A., Rushby, A. (eds) Therapeutics in Rheumatology. Cambridge University Press, 2. pp 209-241
11. Gund, P., Jensen, N. P. (1983) Non-steroidal anti-inflammatory and anti-arthritic drugs. In: Topliss, J. G.(ed.) Quantitative Structure-Activity Relationships of Drugs. Academic Press, New York, pp 285-387
12. 2 release by salicylates, benzoates and phenols: a quantitative structure-activity study. J. Pharm. Pharmacol. 274: 718-723
13. Harman, R. E., Meisinger, M. A. P., Davis, G. E., Kuehl, F. A. (1964) Metabolites of indomethacin, an anti-inflammatory drug. J. Pharmacol. Exp. Ther. 143: 215-220
14. Hughes, M. F., Mason, R. P., Eling, T. E. (1988) Prostaglandin hydroperoxidase-dependent oxidation of phenylbutazone: relationship to inhibition of prostaglandin cyclooxygenase Mol. Pharmacol. 34: 186-193
15. Joesten, M. D., Schaad, L. J. (1974) Hydrogen Bonding. Dekker, New York
16. Kaltenbronn, J. S., Scherrer, R. A., Short, F. W., Jones, E. M., Beatty, H. R., Saka, M. M., Winder, C. V., Wax, J., Williamson, W. R. N. (1983) Structure-activity relationships in series of anti-inflammatory N-arylanthranilic acids. Arzneim. Forsch. 33(1): 621-627
17. Kuchar, M., Rejholec, V., Grimová, J. (1989) Use of QSAR in design of antiinflammatory arylalkanoic acids. In: QSAR: Quantitative Structure-Activity Relationships in Drug Design. Alan R. Liss, Inc , pp 357-360
18. Leahy, D. E., Taylor, P. J., Wait, A. R. (1989) Model solvent systems for QSAR. Part 1. Propylene glycol dipelargonate (PGDP), new standard solvent for use in partition coefficient determination. Quant. Struct.-Act. Relat. 8: 17-31
19. Leahy, D. E , Morris, J. J., Taylor, P. J., Wait, A. R. (1992) Model solvent systems for QSAR. Part 2. Fragment values for the 'Critical Quartet'. J. Chem. Soc. Perkin Trans. 2: 723-731
20. Moser, P., Sallman, A., Wiesenberg, I. (1990) Synthesis and quantitative structure-activity relationships of diclofenac. J. Med. Chem. 33: 2358-2368
21. Nakashima, Y., Kawashima, Y., Sato, M., Okuyama, S., Amanuma, F., Sota, K., Kameyana, T. (1985) Furo[3,2-b]indole derivatives. II. Synthesis and analgesic and anti-inflammatory activities of 4-alkoxycarbonyl-2-morpholinocarbonylfuro[3,2-b]indole derivatives. Chem. Pharm. Bull. 33: 5250-5257
22. Otterness, I. G., Bliven, M. L. (1985) Laboratory models for testing non-steroidal antiinflammatory drugs. In: Lombardino, J. G. (ed.) Nonsteroidal Antiinflammatory Drugs. John Wiley Sons. New York, pp 112-252
23. Rome, L. H., Lands, W. E. M. (1975) Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs. Proc. Natl. Acad. Sci. USA 72: 4863-4865
24. Shen, T. Y. (1979) Prostaglandin synthetase inhibitors. I. In: Vane, J. R., Ferreira, S. (eds) Anti-inflammatory Drugs. H. Springer, Berlin, pp 305-347
25. Shen, T. Y., Winter, C. A. (1977) Chemical and biological studies on indomethacin, sulindac, and their analogs. Adv. Drug Res. 12: 89-245
26. Swingle, K. F. (1974) Evaluation for anti-inflammatory activity. In: Scherrer, F. A., Whitehouse, M. W. (eds) Anti-inflammatory Agents. Medical Chemistry 13/11, Academic Press, New York, pp 34-122
27. van Arman, C. G. (1979) Oedema and vascular permeability. In: Sherrer, F. A., Ferreira, S. H.(eds) Handbook of Experimental Pharmacology, 50/11, Springer, Berlin, pp 75-91
28. Vane, J. R. (1971) Inhibition of prostaglandin synthesis as mechanism of action for aspirin-like drugs. Nature (New Biol.) 231: 232-235
29. Williams, K. M. (1990) Enantiomers in arthritic disorders. Pharmacol. Ther. 46: 273-295